KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation-Reference-Cited by-同舟云学术

KDM5A silencing transcriptionally suppresses the FXYD3‐PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR‐433 up‐regulation

Published:2021-02-23 Issue:8 Volume:25 Page:4040-4052
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Ma Yu‐Shui¹²³,Wu Ting‐Miao²,Qian Bin⁴,Liu Yu‐Shan⁵,Ding Hua⁶,Fan Ming‐Ming⁷,Liu Ji‐Bin³,Yu Fei⁸,Wang Hui‐Min³,Shi Yi³,Gu Li‐Peng¹,Li Liu¹,Tian Lin‐Lin¹,Wang Pei‐Yao¹,Wang Gao‐Ren⁶,Wu Zhi‐Jun⁹,Zou Qi‐Fei⁷,Ling Chang‐Chun¹⁰,Fu Da¹²^ORCID

Affiliation:

1. Central Laboratory for Medical Research Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai China

2. Department of Radiology The Forth Affiliated Hospital of Anhui Medical University Hefei China

3. Cancer Institute Nantong Tumor Hospital Nantong China

4. Department of General Surgery Shanghai Eighth People's Hospital Shanghai China

5. Department of Pathology Nantong Tumor Hospital Nantong China

6. Department of Radiotherapy Nantong Tumor Hospital Nantong China

7. Department of Biliary Surgery IV Eastern Hepatobiliary Surgery Hospital Shanghai China

8. Department of Nuclear Medicine Shanghai Tenth People’s Hospital Tongji University School of Medicine Shanghai China

9. Department of Oncology Nantong Second People's Hospital Nantong China

10. Department of General Surgery The Affiliated Hospital of Nantong University Nantong China

Funder

National Natural Science Foundation of China

Wu Jieping Medical Foundation

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16371

Reference42 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Epidemiology and management of hepatocellular carcinoma;Kulik L;Gastroenterology,2019

3. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation;Heidelbaugh JJ;Am Fam Phys,2006

4. Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma

5. Local-Regional Treatment of Hepatocellular Carcinoma

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging roles of histone demethylases in cancers;Cancer and Metastasis Reviews;2024-01-16

2. MicroRNAs as the critical regulators of tumor angiogenesis in liver cancer;Pathology - Research and Practice;2023-11

3. The roles of FXYD family members in ovarian cancer: an integrated analysis by mining TCGA and GEO databases and functional validations;Journal of Cancer Research and Clinical Oncology;2023-10-09

4. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the KDM5A/FBP1 axis;Environmental Toxicology;2023-09-15

5. Inactivation of KDM5A suppresses growth and enhances chemosensitivity in liver cancer by modulating ROCK1/PTEN/AKT pathway;European Journal of Pharmacology;2023-02